Proprietary Strain Portfolio
Targeted Symptom Management
Key Facts
About InterCure
InterCure's mission is to improve patients' quality of life through the development and global distribution of high-quality, pharmaceutical-grade cannabis products. Its key achievement is establishing a leading, vertically integrated position in Israel's medical cannabis market through its GMP-certified subsidiary, Canndoc. The company's strategy focuses on leveraging its clinical data, regulatory expertise, and production standards to expand into international markets and build a robust evidence-based medical franchise.
View full company profile